How long is the lead time for production?

The average lead time is 1-3 months for both peak and off-peak seasons.

What payment terms do you accept?

We accept LC, T/T, D/P, PayPal, small-amount payments, and Western Union.

Is quality inspection performed on finished products?

Yes, we perform 100% inspection including visual and function checks on all finished products.

500ml

Name: Glucose (Dextrose) Injection 5%/10% in Plastic Bottle 50ml/100ml/250ml/500ml
Brand: Shandong Shenglu Pharmaceutical Co., Ltd.
SKU: 1961344571

Shandong, ChinaShandong Shenglu Pharmaceutical Co., Ltd.

US$0.10

20 Pieces

Product profile

Customization

Available

Application

Internal Medicine

Usage Mode

Suitable for

Elderly, Children, Adult

State

Liquid

Shape

Injectable

Type

Organic Chemicals

Pharmaceutical Technology

Chemical Synthesis

Pharmaceutical Technology

Bp/Cp/USP, etc.

Registration Dossiers

Available

GMP

Support

Transport Package

30 Bottles/ Carton

Specification

0.9%

Trademark

Ocean/OEM

Origin

China

Key features

Customizable Production: Accepts contract production and customizes according to client requirements including packaging and labels.

Multiple Dosage Options: Available in 50ml, 100ml, 250ml, 500ml, and 1L plastic bottles to meet diverse needs.

Pharmaceutical Standards: Technology compliant with BP, CP, USP, and other international standards.

OEM and ODM Services: Full OEM and ODM support including artwork design and registration document assistance.

Comprehensive Quality Control: 100% visual and function inspection for finished products with traceable raw materials.

Versatile Application: Suitable for elderly, children, and adults for nutrition support and treating low blood sugar.

Established Manufacturer: Company established in 2001 with over 20 years of export experience and professional R&D team.

Flexible Packaging: Customizable packaging materials and label options, including plastic bag availability.

Company profile

Years of Export ExperienceHigh Repeat Buyers ChoiceIn-stock Capacity100% Finished Products Inspection

Shandong Shenglu Pharmaceutical Co., Ltd.

Shandong, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 20 Years CertifiedNearest Port: Qingdao PortAverage Response Time: ≤15h

AI-Powered supplier vetting

SummaryThe supplier demonstrates substantial pharmaceutical production capacity, national GMP certification, stable-quality claims, broad customization, OEM/ODM services, export experience, inventory capacity, and documented complaint/CAPA procedures. However, it is not identified as a professional technical supplier, lacks 3D software and SDK capabilities, reported no new products in the past year, and has no overseas agents, branches, warehouses, showrooms, or offline trade-show participation. Financial records are referenced for 2021–2023, but the provided information does not establish financial strength. Supplier-approval documentation lacks signatures or dates, while environmental and fire-drill evidence remains unknown.

Supplier typeThe supplier is presented as a pharmaceutical manufacturer with stated capacity for small-volume injections, tablets, capsules, and powder injections, and it provides OEM/ODM services. It is explicitly not classified as a professional technical supplier, so its primary profile is manufacturing rather than technical-service provision.

CertificationsThe company description states that the supplier has passed national GMP certification. This is direct evidence of a relevant pharmaceutical manufacturing certification, although no additional certifications are provided.

After-Sales capabilityThe supplier has clear and followed procedures for customer complaints and corrective/preventive actions, and it maintains quality assurance. However, it has no overseas agents or branches, no overseas warehouse or showroom, and offers overseas services in zero countries, limiting evidence of broad international after-sales coverage.

R&D capabilityThe supplier does not provide 3D software design services, has no available SDK, and reported no new products in the past year. Although it offers ODM services and design-based customization, the explicit evidence indicates limited demonstrated product and technical innovation.

Production capacityThe supplier reports large annual pharmaceutical production capacity, inventory capability, valid manufacturing contracts with associated subcontractors, and national GMP certification. These points directly support substantial and organized manufacturing capability.

Customization capabilityThe supplier explicitly offers customization from samples, customization from designs, full customization, and minor customization, as well as ODM services. This demonstrates broad customization coverage despite the absence of 3D software design services.

Client casesThe supplier reports that 71%–90% of total sales come from exports, has exported goods for 20 years, and provides OEM services for well-known brands. These statements support relevant customer and international business experience, although specific customer names or case details are not supplied.